190 related articles for article (PubMed ID: 38566872)
1. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study.
Dini G; Santini MG; Celi F
Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872
[TBL] [Abstract][Full Text] [Related]
2. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
3. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
[TBL] [Abstract][Full Text] [Related]
4. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
Mishra A; Joshi A; Londhe A; Deshmukh L
Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
[TBL] [Abstract][Full Text] [Related]
5. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
Halim A; Shirazi H; Riaz S; Gul SS; Ali W
J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
[TBL] [Abstract][Full Text] [Related]
6. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis.
Mansouri M; Servatyari K; Rahmani K; Sheikhahmadi S; Hemmatpour S; Eskandarifar A; Rahimzadeh M
J Neonatal Perinatal Med; 2024; 17(2):233-239. PubMed ID: 38759030
[TBL] [Abstract][Full Text] [Related]
7. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
[TBL] [Abstract][Full Text] [Related]
8. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
[TBL] [Abstract][Full Text] [Related]
9. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
[TBL] [Abstract][Full Text] [Related]
10. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
11. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Preterm Respiratory Care in Ukraine: An Observational Study of Outcomes in Relation to Timing and Methods of Surfactant Treatment.
Dobryanskyy DO; Menshykova AO; Salabay ZV; Detsyk OY
Am J Perinatol; 2022 Jun; 39(8):889-896. PubMed ID: 33152767
[TBL] [Abstract][Full Text] [Related]
13. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?
Kakkilaya V; Gautham KS
Pediatr Res; 2023 Apr; 93(5):1188-1198. PubMed ID: 35986148
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive surfactant therapy
Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
[TBL] [Abstract][Full Text] [Related]
15. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
[TBL] [Abstract][Full Text] [Related]
16. A clinical study evaluating the combination of LISA and SNIPPV for the treatment of respiratory distress syndrome in preterm infants.
Permall DL; Zhang Y; Li H; Guan Y; Chen X
Sci Rep; 2024 Jan; 14(1):1429. PubMed ID: 38228632
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of less invasive surfactant administration using video laryngoscopy in extremely preterm infants.
Baczynski M; Deekonda V; Hamilton L; Lindsay B; Ye XY; Jain A
Pediatr Res; 2023 Mar; 93(4):990-995. PubMed ID: 35854087
[TBL] [Abstract][Full Text] [Related]
18. Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries.
Sk MH; Saha B
Pediatr Int; 2023; 65(1):e15668. PubMed ID: 38009628
[TBL] [Abstract][Full Text] [Related]
19. The Comparison of LISA and INSURE techniques in term of neonatal morbidities and mortality among premature infants.
Silahli M; Tekin M
Acta Biomed; 2020 Nov; 91(4):e2020189. PubMed ID: 33525282
[TBL] [Abstract][Full Text] [Related]
20. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
[No Abstract] [Full Text] [Related]
[Next] [New Search]